November 8, 2017 / 12:38 PM / a month ago

BRIEF-Pacira Pharmaceuticals reports Q3 non-gaap earnings per share $0.11

Nov 8 (Reuters) - Pacira Pharmaceuticals Inc

* Pacira Pharmaceuticals Inc reports third quarter 2017 financial results

* Q3 non-gaap earnings per share $0.11

* Q3 gaap loss per share $0.19

* Q3 revenue $67.3 million versus I/B/E/S view $69.6 million

* Q3 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S

* Pacira Pharmaceuticals Inc - ‍Full-year exparel net product sales guidance revised to $280 to $285 million​

* Pacira Pharmaceuticals Inc - ‍Updating its full year 2017 sales guidance and reiterating its remaining financial guidance​

* FY2017 revenue view $291.8 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below